Search filters

Overall survival for sorafenib plus interleukin-2 compared with sorafenib alone in metastatic renal cell carcinoma (mRCC): final results of the ROSORC trial

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article published on 24 September 2013
Author/s

author: Italian Melanoma Intergroup  Rosalba Miceli  Elena Verzoni  Camillo Porta  Giuseppe Procopio 

Publication date September 24, 2013
Language
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item